The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital (MGH), has been awarded a Project Grant of $798,848.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The project, titled "The Skull Bone Marrow Niche After Stroke," aims to examine the post-stroke information transfer between the central nervous system (CNS) and the skull marrow, which may serve as a specialized producer of leukocytes to the CNS. This research seeks to understand how the skull marrow niche, which is directly connected to the CNS borders via channels, may influence brain health and post-stroke inflammation. The award period is from March 1, 2025 to February 28, 2029.
Generated 3/18/25, 3:24 AM